Treatment Outcomes in Patients Treated With Galcanezumab vs Placebo: Post Hoc Analyses From a Phase 3 Randomized Study in Patients With Episodic Cluster Headache

BACKGROUND: Cluster headache (CH) is a highly disabling primary headache disorder. To date, characterization of outcomes in the preventive treatment of episodic CH, including precise definitions of clinically meaningful attack frequency reduction and impact on acute treatment management, is lacking....

Descripción completa

Detalles Bibliográficos
Autores principales: Kudrow, David, Andrews, J. Scott, Rettiganti, Mallikarjuna, Oakes, Tina, Bardos, Jennifer, Gaul, Charly, Riesenberg, Robert, Wenzel, Richard, Kuruppu, Dulanji, Martinez, James
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research Submissions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7756634/
https://www.ncbi.nlm.nih.gov/pubmed/33179263
http://dx.doi.org/10.1111/head.14011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7756634/
https://www.ncbi.nlm.nih.gov/pubmed/33179263
http://dx.doi.org/10.1111/head.14011

Ejemplares similares